Azitra, Inc. (AZTR) vs CytoMed Therapeutics Limited (GDTC)

Azitra, Inc. and CytoMed Therapeutics Limited are both Biotechnology companies. Azitra, Inc. and CytoMed Therapeutics Limited are of similar size ($10.8M and $10.1M). CytoMed Therapeutics Limited has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 2.5×. Across the 11 metrics below, Azitra, Inc. leads on 6 and CytoMed Therapeutics Limited on 5.

Valuation

Metric AZTR GDTC Biotechnology median
P/E 2.54 n/m 7.88
P/S 5.66 n/m 11.47
P/B 0.45 488.81 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.31 n/m 0.74
EV/Sales (5.94) n/m 10.73
Earnings yield 39.35% (29.17%) (28.84%)
Free cash flow yield (346.99%) (0.35%) (23.03%)

Profitability

Metric AZTR GDTC Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (256.67%) 0.00% (57.72%)
Return on assets (190.69%) 0.00% (49.22%)
Return on invested capital (1,272.49%) 0.00% 0.00%

Growth

Metric AZTR GDTC Biotechnology median
Revenue growth (TTM) 58.18% — 5.64%
EPS growth (last fiscal year) 85.67% (68.75%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AZTR GDTC Biotechnology median
Debt to equity 0.00 0.07 0.00
Current ratio 4.86 5.17 4.73
Net debt to EBITDA 0.20 0.86 0.96

Dividend

Metric AZTR GDTC Biotechnology median
Dividend yield — — 2.10%
Payout ratio — — 0.00

Size

Metric AZTR GDTC Biotechnology median
Market cap 10.10m 10.77m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack